首页> 外文期刊>The Journal of Urology >Pathophysiology of unilateral ureteral obstruction: studies from charlottesville to new york.
【24h】

Pathophysiology of unilateral ureteral obstruction: studies from charlottesville to new york.

机译:单侧输尿管梗阻的病理生理学:从夏洛茨维尔到纽约的研究。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE:: More than 30 years ago the decreased renal blood flow and glomerular filtration rate characteristic of unilateral ureteral obstruction (UUO) was described. In the ensuing time, much has been learned about the involvement of nitric oxide (NO) and transforming growth factor-beta (TGF-beta) in the pathophysiology of UUO. MATERIALS AND METHODS:: We measured renal blood flow and glomerular filtration rate in dogs and rats, and assessed the effect of altering the availability of NO on these parameters. In rats and mice we used an antibody to TGF-beta, NO synthase gene deletion and inducible nitric oxide synthase gene therapy to assess the role of TGF-beta and NO in renal fibrosis. RESULTS:: Results of our studies suggest 2 strategies that have the potential to be incorporated into clinical trials. The first would be replenishment of the NO system with arginine (or a NO donor) to decrease renovascular resistance and increase renal nitric oxide. Either in addition to the first strategy or separately,interstitial fibrosis could be targeted. Strategies for inhibiting fibrosis include antibody to TGF-beta, use of antisense oligonucleotides to TGF-beta, use of drugs that inhibit other pro-fibrotic mediators or gene therapy to inhibit fibrosis. CONCLUSIONS:: While these studies have primarily centered on acute UUO, the findings in this model of renal injury may potentially be transferable to other entities that are characterized by decreased renal function and increased renal fibrosis such as different forms of interstitial nephropathy or diabetic glomerulopathy.
机译:目的:30年前,描述了单侧输尿管阻塞(UUO)的肾血流量减少和肾小球滤过率特征。在随后的时间里,关于一氧化氮(NO)和转化生长因子-β(TGF-β)参与UUO病理生理学的知识很多。材料与方法::我们测量了狗和大鼠的肾血流量和肾小球滤过率,并评估了改变NO有效性对这些参数的影响。在大鼠和小鼠中,我们使用了抗TGF-β抗体,NO合酶基因缺失和诱导型一氧化氮合酶基因治疗,以评估TGF-β和NO在肾纤维化中的作用。结果:我们的研究结果提出了2种可能被纳入临床试验的策略。首先是用精氨酸(或NO供体)补充NO系统,以降低肾血管阻力并增加一氧化氮。除了第一种策略外,也可以单独针对间质纤维化。抑制纤维化的策略包括针对TGF-β的抗体,使用针对TGF-β的反义寡核苷酸,使用抑制其他促纤维化介质的药物或基因疗法来抑制纤维化。结论:尽管这些研究主要集中在急性UUO上,但是这种肾脏损伤模型的发现可能可以转移到其他以肾功能下降和肾纤维化为特征的实体,例如不同形式的间质性肾病或糖尿病性肾小球病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号